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Objectives. To determine the effect of pre-operative factors on mid-term survival of patients enrolled in an Australian
audit of endovascular aneurysm repair (EVAR).
Design. Prospective longitudinal national register (audit) of patients undergoing EVAR.
Methods. 961 individuals who had elective or semi-urgent EVAR of abdominal aortic aneurysms were enrolled in the audit
between November 1999 and May 2001. Data was contributed by 81 surgeons from 64 hospitals.
Kaplan-Meier survival analysis was used to determine survival rates and factors significantly influencing survival.
Parametric survival analysis with log-exponential distribution was used to estimate expected 3 and 5 year survival for
different ages, ASA, creatinine and aneurysm sizes.
Results. Overall survival was 93% at 1 year, 80% at 3 years and 67% at five years. Survival rates were found to be
statistically associated with ASA, age, aneurysm size and creatinine levels. ASA has the largest effect. Five year survival
rates for aneurysms 65 mm and <55 mm were 54% and 76% respectively. Pre-operative creatinine levels 160 mmol/L
lowered the survival rate from 71% to 40%.
Conclusions. Survival for EVAR patients is strongly correlated with a number of pre-operative factors. This survival
analysis provides a useful decision-making tool for surgeons particularly for individuals with smaller aneurysms.
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In 1999, a report prepared for the Australian Govern-
ment found that the long-term outcomes of endo-
vascular aneurysm repair (EVAR) were not well
defined.1 As a consequence, the Government funded
a longitudinal national audit of the procedure, under-
taken by the Royal Australasian College of Surgeons
(RACS), with the aim of using the results to provide
additional information regarding the safety and effi-
cacy of the procedure.
This paper is based on the statistical analysis of
data during the seventh year of the audit, and pres-
ents information on the influence of preoperative fac-
tors on mid-term survival of EVAR patients. Mortality
data was obtained from the National Death Index
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E-mail address: college.asernip@surgeons.org1078–5884/000156+ 07 $32.00/0  2007 Elsevier Ltd. All rights resewhich contains the records for all deaths occurring
in Australia from 1980.
Being a national audit, patients exhibit a wide
range of aneurysm morphology and pre-operative pa-
tient characteristics. For instance, the Australian audit
has previously highlighted that in ‘‘real’’ practice the
procedure is frequently used on smaller aneurysms2
despite evidence suggesting that conservative treat-
ment is the preferred option for aneurysms smaller
than 55 mm.3,4,5
The EVAR procedure has been used increasingly by
vascular surgeons since its inception, despite ongoing
uncertainty over its longer term durability and effec-
tiveness. Figures provided by Medicare Australia
show that in Australia the number of EVAR proce-
dures performed in 2000 and 2006 within the private
system more than doubled (from 237 in 2000 to 570
in 2006). At the same time the number of open repairs
of abdominal aortic aneurysms decreased from 465 to
349 (25%).rved.
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preoperative factors which may influence the survival
of an EVAR patient.
Methods
Ethics approval and governance
Ethics approval for the audit was obtained from the
Ethics Committee for the Royal Australasian College
of Surgeons. A reference group of vascular surgeons
provides advice on clinical aspects of EVAR repair.
Participating surgeons obtained informed consent
from patients.
Audit of EVAR
Operative data for patients who underwent elective or
semi-urgent EVAR between the 1 November 1999 and
16 May 2001 were collected from vascular surgeons
and entered into a central Access (Microsoft) data-
base. Cross-checking of private cases with Medicare
Australia (formerly the Health Insurance Commis-
sion) indicated a compliance rate of >90%. Annual
follow-up of all patients will continue until 2008.
Mortality data for patients enrolled in the audit
were obtained from the Australian Institute of Health
and Welfare’s National Death Index in November
2004, September 2005 and August 2006.
Using standard data forms, a range of pre-operative
informationwas collected for items such as age, gender,
ASA, aneurysmmorphology, creatinine and suitability
for open repair. Copies of data entry forms are available
from the RACS website (http://www.surgeons.org/
asernip-s/audit.htm). Patient fitnesswasmeasured us-
ing theAmerican Society ofAnaesthesiology (ASA) rat-
ing. Details of the procedure, additional procedures
and any complications arising either immediately
following the procedure or prior to discharge were col-
lected. Follow-up data sought to identify graft related
problems, changes in aneurysm size and additional
aneurysm related procedures.
The main type of device deployed between 1999
and 2001 was the Zenith graft (Cook Australia) 82%.
Other types of graft used were: Ancure (Guidant)
1.5%, AneurRx (Medtronic) 7%, Excluder (WL Gore)
4.5%, Talent (World Medical) 3.8% and Vanguard
(Boston Scientific) 0.7%.
Data interpretation
Peri-operative mortality is defined as death within
30 days of the procedure. Aneurysm-related death(ARD) is defined as any death occurring within
30 days of the primary or any secondary procedure
or any ARD such as rupture occurring at any time
following the primary procedure.
Independent statistical analyses were undertaken
by the Commonwealth Scientific and Industrial Re-
search Organisation (CSIRO) to evaluate the effect of
pre-operative factors such as age, gender, smoking
status, graft configuration and device type (manufac-
turer), ASA, pre-existing conditions, fitness for the
open procedure, renal function (creatinine), aneurysm
size, aortic neck and aneurysm angle and aortic neck
length on survival and ARD. Some pre-operative vari-
ables were not selected for statistical analysis if they
were subjective, ambiguous or highly incomplete
(e.g. tortuosity and calcification).
Stratified, right censored, Kaplan-Meier Survival
analysis was utilized to determine the survival rates
and factors significantly influencing survival, using
the log rank (Mantel-Haenszel) test. Freedom from
ARD was similarly assessed.6
Survival curves and table (Table 2) were produced
using rounded months until death, or until last
known to be alive, for simplicity of interpretation.
The last time a person is known to be alive is either
the last date that the Australian Death Mortality Index
registry was interrogated or the last follow-up date,
whichever occurred later. Patients who are still alive
are considered censored because we do not know
how long they will survive.
The rounded months used for graphs and Table 2
were 0, 1, 3, 6, 12, 24, 36, 48, 60 and 72 months.
S-Plus surv() function Version 6.2.1 2003 Insightful
Corp. was used to produce survival table and curves.7
Parametric survival analysis with log-exponential
distribution was used to estimate expected 3 and
5 year survival for different ages, ASA, creatinine
and aneurysm sizes (Tables 3 and 4). Parametric sur-
vival analysis was seen to be a more appropriate
method to estimate the survival rates for continuous
variables (size, age, ASA and creatinine). The log
exponential distribution was used because it has the
lowest residual log likelihood and requires one less
parameter estimate than other distributions such as
Weibull, Gaussian, or logistic.
Results
Preoperative and operative information
A total of 961 patients who underwent EVAR during
November 1999 and May 2001 were enrolled in
the Australian audit. Data were contributed by
158 M. Boult et al.81 surgeons for procedures performed at 64 institu-
tions. Some patient baseline characteristics are shown
below and in Table 1. Additional baseline information
is reported in the audit annual reports (http://www.
surgeons.org/asernip-s/audit.htm) and in previous
publications.2,8
The mean age (SD) of patients at the time of the
procedure was 75.0 6.9 years. Twenty three percent
(223/961) of patients were 80 years or older and 7%
were under 65 years (70/961). Male patients predomi-
nated in the audit (86%, 828/961). Thirty four percent
of patients were listed as healthy or had only mild
systemic conditions (i.e. ASA I or II). The majority of
patients were ASA III (559/945). The majority of
patients had normal renal function, as measured by
pre-operative creatinine< 120 mmol/L (66.6%, 604/
907). 21.3% of patients had mid-range creatinine
(120e159 mmol/L, 193/907) and 12.1% had high creat-
inine (160 mmol/L, 110/907). Females were signifi-
cantly more likely to have had hypertension prior to
surgery than males (77% vs 69%, p¼ 0.04). For age
(t-Test: Two-Sample Assuming Unequal Variances)
and ASA (Chi-squared test) the patient profiles were
not significantly different when the data was analysed
by gender.
Pre-operative aneurysm characteristics are shown
by gender in Table 1.
When surgeons were asked to report the suitability
of their patients for the open procedure their response
indicated that 43% of their patients (411/961) were
unsuitable candidates for open repair, the predomi-
nant reason stated being co-existent morbidities
(77%, 316/411). Good prognostic indicators for a pa-
tient to be deemed suitable for open repair by their
surgeon included ASA (ASA I and ASA II: 13%
unsuitable v 51% suitable, p< 0.001), number of co-
morbidities (mean number 3.5 v 2.2; p< 0.001), age
(76.4 years unsuitable v 74.1 years suitable, p< 0.001)
Table 1. Preoperative aneurysm morphology
Male Female Significant
difference
p< 0.05
Mean aneurysm
diameter [SD]y
57.9 [10.5] 54.7 [9.0] yes
Aneurysm
diameter< 55 mm*
42% (338/799) 55% (73/132) yes
Infrarenal neck
length 15 mm*
17% (128/747) 19% (24/125) No
Infrarenal neck
diameter >28 mm*
8% (61/751) 6% (8/126) No
Thrombus in neck* 12% (90/755) 12% (15/129) No
Saccular aneurysm* 21% (156/745) 24% (30/123) No
* chi-squared test.
y t-Test: Two-Sample Assuming Equal Variances.
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suitable, p< 0.001).
Mid-term mortality and morbidity
Early or peri-operative mortality for patients enrolled
in the Australian audit was 1.8% (17/961). By August
2006, 40% (374/961) of audit patients had died.
2.5% of deaths were identified as aneurysm related
(24/961). Aneurysm related deaths included death
within 30 days of the original procedure (13), death
due to rupture (9) or mortality within one month of
a secondary procedure (2). A further 14 patients had
the ICD-10 code¼ I714 ‘‘abdominal aortic aneurysm
without rupture’’ (13), or I72.3 ‘‘aneurysm of iliac
artery’’ (1) as the primary cause of death provided
by the National Death Index. These two ‘cause of death’
descriptors are ambiguous and may not necessarily
indicate ARD.
Overall, 23 patients had their EVAR converted to
open repair (2.4%). Eight conversions happened
during or soon after primary surgery (two following
rupture). The mean time to late conversion was
36 months. Reasons for late conversions included rup-
ture (3), enlargement of the aneurysm (4), infected
graft (3), migration and endoleak (2), type I endoleak
(1), thrombosed graft (1) and unspecified (1).
At August 2006, 16 patients had ruptured aneu-
rysms (1.7%). Three ‘‘early’’ ruptures occurred within
30 days of the original procedure. One patient died
and two survived following conversion to open re-
pair. Thirteen ‘‘late’’ ruptures have been reported of
which 9 patients died as a consequence, three patients
survived following open repair and one survived
following repeat endovascular repair.
Preoperative aneurysm size was significantly larger
for the patients whose aneurysms ruptured (68.5 mm
vs 57.3 mm, p< 0.001).
Statistical analysis of results
Table 2 shows the survival data for all patients
enrolled in the audit.
Essentially 3 years following EVAR, 80% of patients
can be expected to survive. Similarly, after five years
67% of patients can be expected to survive.
The angle of the aortic neck, infra-renal neck
length, device brand, smoking status, graft configura-
tion, aneurysm angle, and gender had non-significant
effects on survival (i.e. p> 0.05). Four factors were
shown to statistically significantly impact on survival:
age, ASA, creatinine and aneurysm size as shown in
Figs. 1e4. Each factor was found to contribute
159Factors Affecting Survival after EVARTable 2. Survival table for all patients.
Time (months) Number entering
this interval
Number of deaths Proportion surviving Survival Standard error Lower 95% CI Upper 95% CI
0 961 3 99.7% 0.2% 99.3% 100.0%
1 958 16 98.0% 0.4% 97.1% 98.9%
3 942 9 97.1% 0.5% 96.0% 98.2%
6 933 14 95.6% 0.7% 94.3% 96.9%
12 919 29 92.6% 0.8% 91.0% 94.3%
18 890 33 89.2% 1.0% 87.2% 91.2%
24 857 30 86.1% 1.1% 83.9% 88.3%
36 3 yr 827 57 80.1% 1.3% 77.6% 82.7%
48 770 56 74.3% 1.4% 71.6% 77.1%
60 5 yr 714 68 67.2% 1.5% 64.3% 70.3%
72 646 47 62.3% 1.6% 59.3% 65.5%
96 243 12 59.3% 1.7% 56.0% 62.7%statistically significantly to a model of survival with
each p< 0.001. Three and five year survival rates are
shown on each figure. Infrarenal neck diameter was
statistically significant for 3 year survival (0.006), but
not 5 year survival (p¼ 0.093).
Age statistically significantly contributes to the
survival model which already accounts for ASA
(p< 0.001), using a likelihood ratio test7 comparing
survival models of ASA, with and without age.
Aneurysm size (p¼ 0.001) similarly was found to sta-
tistically significantly contribute to explain the varia-
tion in survival rates, when added to a model
which already included age and ASA. Creatinine
(p< 0.001) further statistically significantly contrib-
uted to explain the variation in survival rates, when
added to a model which already included age, size
and ASA.
Tables 3 and 4 show predicted survival of patients
after EVAR at three years and five years, for patients
with particular preoperative aneurysm size, ASA,
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Fig. 1. Age.creatinine and age. These tables show the effect of
all four variables on survival in contrast to their sin-
gular effect shown in the figures. The best case sce-
nario shown in Tables 3 and 4 is for a young patient
(70 years) with low ASA, a small aneurysm (50 mm)
and with low creatinine (85 mmol/L). We expect 91%
of such patients to survive 3 years and expect 85%
patients to survive 5 years (i.e. 15% expected to die
within 5 years). The worst case scenario shown in
Tables 3 and 4 is for an older patient (83 years), with
high ASA (IV), with a large aneurysm(74 mm) and
with high creatinine(125 mmol/L). For this worst
case we expect 44% patients to survive 3 years and
only 25% to survive 5 years (i.e. 75% expected to die
within 5 years).
Grey shading in Tables 3 & 4 indicates unreliable
estimates, showing where there were less than 10 peo-
ple in the region estimated. These have been included
for completeness, but should not be treated as accu-
rate estimates of survival rates.
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Stratified, right censored, Kaplan-Meier survival
analysis was used to determine which factors signif-
icantly influenced ARD. Results indicated that ASA
(p¼ 0.002), aneurysm size (p¼ 0.001) and infrarenal
neck length (p¼ 0.001) all significantly contributed
to a model of freedom from ARD. Gender, age, aortic
neck angle, device, graft type, infrarenal neck diame-
ter, smoking status, aneurysm angle and creatinine
were not found to statistically significantly predict
ARD. Finding significant differences despite the
small number of (24) of ARD, implies these have
a strong effect. Table 5 shows the direction and mag-
nitude of these affects; the observed ARD rates are
reported.
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The management of abdominal aortic aneurysms
remains controversial and this is particularly true
for sicker patients (ASA III and IV) with smaller aneu-
rysms (<55 mm). The data presented here provides
robust information which can help inform clinicians
in their decision-making process for patients with
abdominal aortic aneurysms.
Being population based, the Australian audit has
been able to closely follow a large heterogeneous
group of EVAR patients for over six years. For exam-
ple 44% of the 961 patients were treated for aneu-
rysms smaller than 55 mm and 65%were ASA III or IV.
The 30-day mortality for EVAR cases submitted to
the Australian audit was 1.8% which is similar to
results reported elsewhere.9
In this Australian study, the overall three year
survival post EVAR is 80% and 67% at five years.
Table 3. Survival at three years predicted by ASA, age and aneu-
rysm size
ASA Max
Diameter
Age (years)
70 years 77 years 83 years
Creatinine (mMoles/Litre)
85 125 85 125 85 125
ASA II 50 mm 91% 88% 87% 84% 83% 79%
58 mm 89% 87% 86% 82% 81% 77%
74 mm 87% 83% 82% 77% 77% 71%
ASA III 50 mm 86% 82% 81% 76% 75% 69%
58 mm 84% 80% 78% 73% 72% 66%
74 mm 80% 75% 73% 67% 66% 59%
ASA IV 50 mm 79% 74% 72% 65% 64% 56%
58 mm 76% 71% 69% 62% 60% 52%
74 mm 71% 64% 62% 54% 53% 44%
Shading denotes estimates with low certainty. Sample sizes <10 in
those regions.
Table 4. Survival at five years predicted by ASA, age and aneu-
rysm size
ASA Max Diameter Age (years)
70 years 77 years 83 years
Creatinine (mMoles/Litre)
85 125 85 125 85 125
ASA II 50 mm 85% 81% 79% 74% 74% 68%
58 mm 83% 79% 77% 72% 71% 64%
74 mm 79% 74% 72% 65% 64% 57%
ASA III 50 mm 77% 72% 70% 63% 62% 54%
58 mm 75% 69% 67% 60% 58% 50%
74 mm 69% 62% 60% 52% 50% 41%
ASA IV 50 mm 67% 60% 57% 49% 48% 39%
58 mm 64% 56% 53% 45% 43% 34%
74 mm 56% 48% 45% 36% 34% 25%
Shading denotes estimates with low certainty. Sample sizes <10 in
those regions.
161Factors Affecting Survival after EVAR
Eur J Vasc Endovasc Surg Vol 34, August 2007We found, however, that a number of pre-operative
factors are strongly predictive of mid-term survival.
The most powerful single predictor of survival is
ASA status, with ASA II individuals having an 81%
5 year survival , ASA III a 63% survival and ASA IV
patients a 40% 5 year survival. Whilst allocation of
individuals to various ASA groups is somewhat
arbitrary, it is clear that a global assessment of co-
morbidities predicts long-term survival. Similar
findings have been reported by Torsello et al. after
Talent graft deployment.10
As expected, the survival analysis showed that age
at the time of implantation is a strong predictor
(5 year survival in patients less than 75 years of age
is 77% versus 54% in those over 80 years) indicating
strongly to clinicians the impact of patient selection
on clinical outcome.
Renal impairment (reflected by a creatinine level
120 mmol/L) was also found to be a strong predictor
of survival (Fig. 3). Whilst formal glomerular filtration
rates were not calculated, it is clear that modest renal
impairment is a potent predictor of long-term survival
post EVAR. This is consistent with findings by Azizza-
deh et al.11 Similar effects of renal function on outcome
of coronary bypass grafting in high risk individuals
has been found12 and in fact also in patients with
ischaemic heart disease.13
Somewhat surprisingly however, we have also
found that aneurysm size is a significant predictor
of survival (5 year survival in patients with aneu-
rysms <55 mm is 78%, versus 54% in aneur-
ysms 65 mm) and this effect is independent of
ASA and age. Two studies have reported worse
mid-term outcomes for patients with larger preopera-
tive aneurysms.14,15 Ouriel et al. showed significantly
worse 24-month survival for larger aneurysms
( 55 mm) than those less than 55 mm14 The EURO-
STAR collaborators also found that the midterm out-
come for larger preoperative aneurysms resulted in
more ARD, unrelated death and rupture.15 Zarins
et al. observed a significant increase in five year mor-
tality in larger aneurysms.16 It is not clear why this
Table 5. Aneurysm Related Deaths
ASA I or II 1% (4/305)
ASA III 3% (16/568)
ASA IV or V 8% (5/63)
Aneurysm diameter 50 mm 0% (1/253)
Aneurysm diameter 50e55 mm 2% (5/225)
Aneurysm diameter> 55 mm 4% (18/441)
Infrarenal neck length <12 mm 9% (6/66)
Infrarenal neck length 12e20 mm 2% (7/306)
Infrarenal neck length >20 mm 2% (11/476)
Missing data was omitted. Hence totals< 961.should be, and would appear to warrant further
investigation.
Two large randomised controlled trials have dem-
onstrated that surveillance is generally preferable to
open repair for patients whose aneurysms are smaller
than 55 mm.3,4,5 This assessment is based on the rates
of perioperative mortality and the risk of rupture
for the smaller aneurysm. The risk of small aneurysms
(40e50 mm) rupturing is around 1% per
annum.3,4,5,17,18 However, a significant proportion of
aneurysms tend to expand over time, leading to
increased risk of rupture (10e20% for aneurysms
between 60 and 70 mm) and hence the inevitable
requirement for intervention in a subset of patients.17
Given the increasing strength of evidence in favour
of improved survival of patients with smaller aneu-
rysms and the desire of vascular surgeons to use the
EVAR procedure rather than open repair, there may
be good reasons for re-evaluating these recommenda-
tions in selected subgroups of patients, especially
where the expected rate of expansion can be pre-
dicted. However, the ongoing need for reintervention
and continued aortic sac enlargement will also need to
inform the decision making process.19
ASA, aneurysm size, and infrarenal neck length all
significantly influenced ARD. It should be noted how-
ever that ARD only accounted for 2.5% of all deaths in
the study group. This compares with a 3.1% of
patients at twelve years reported by Brewster et al.20
and 0.6% at seven years reported by Torsello et al.10
It is probably reasonable to assume that with this
Australian study 2.5% is a baseline figure and that
additional deaths were aneurysm related, but not
attributed at the time of death, where autopsies are
rarely undertaken in older patients.
Brewster et al. found large pre-operative aneurysm
size to be one predictor of ARD as well as renal insuf-
ficiency, which did not appear to be a predictor in our
study.20 The Eurostar collaborators found no indepen-
dent association of risk factor variables with ARD.21
The association of ARD with infra-renal neck
length appears to be new and requires additional
investigation.
The ability to readily link this patient groupwith the
National Death Index will enable us to review further
causes of mortality and especially ARD during the
next two years of the study.
We have presented survival tables for patients at
three and five years based on the Australian audit
results with subgroups of patients based on aneurysm
size, ASA, and age. The results clearly show the di-
minishing chance of survival for patients with larger
aneurysms, increasing ASA, older age and elevated
creatinine, and could be of use to clinicians and
162 M. Boult et al.patients alike during their pre-operative decision
making process.
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